The FTSE 100 closed in the red on Wednesday, reversing gains made at the start of the week. The blue-chip index was off 2.9 ...

ASX cops a 1.4pc beating as the US-China trade spat rocks markets, pharma faces tariff pain, oil dives, and Aussie ... Read ...

Medical marketers, ad agencies, physicians and pharma executives gathered for MM+M’s annual Transform conference, held at One ...

Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...

The old Chinese curse that runs ‘may you live in interesting times’ holds today much as it ever did. Two days after Donald ...

The president estimates that Elon Musk will step back from government duties in a few months to fully focus on his companies ...

Steinkühler: AI presents a tremendous opportunity in the field of finance, primarily because it facilitates the use and ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...

Dr. Reddy’s share price jumps as U.S. exempts pharma from global tariffs. Indian pharma stocks rally with bullish momentum ...

Rahman discusses Google Gemini and what it could mean to the future of pharma commercialization and content development.

Sandeep Tandon, CIO of Quant Mutual Fund, expresses confidence in India's market recovery potential for April despite recent ...